Two anti-pandemic research achievements of Tsinghua University-affiliated Beijing CapitalBio Technology Co were recently published in internationally influential journals.

One is titled “A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic”, which was jointly published by Tsinghua University and several other medical institutions in the international journal Clinical Chemistry (IF=7.29).

The paper describes the highly automated mobile laboratory’s performance in fast response and deployment of medical diagnosis during the outbreak of infectious diseases.

The paper ‘A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic’ is published in the internationally influential journal Clinical Chemistry.

The lab is installed on a light bus and equipped with a homegrown robot arm for automated oropharyngeal swab specimen collection, a rapid virus inactivator, a fully integrated chip laboratory system and a 5G direct report communication system.

A minibus equipped with the highly automated mobile laboratory

A fully integrated chip laboratory system equipped in the mobile lab